Pick a plan man!
We have a sister website called MedicareDrugPlans.com, where you can find basic information about, well, Medicare drug plans, and read reviews of the plans written by people who have used them, and rate your own plan if you have one. We’ve updated our data to include the plans that will be available in 2017.
Why? It’s that time again to pick a Medicare Part D plan. Doors opened today, October 15, and will close on December 7. If you’re one of 57 million Americans, most of them over 65, who are enrolled in Medicare then you either have a plan or are newly eligible for one. There are many plans (although fewer than there once were) and picking one can be highly aggravating. While online pharmacies, drug prices, and personal drug importation are PharmacyChecker.com’s forte, each year since we started PharmacyCheckerBlog, I’ve tried to write something educational, practical, even funny, about the plans and how to pick one at enrollment time. This year I went nuts. Still, if you read through this post carefully, it will teach you about Part D Medicare drug plans: the good, the bad, and the ugly and give you resources to learn even more. First a very little history… (more…)
Tagged with: Medicare, Medicare Part D, Part D
I’ll keep it real brief today. So far this year, most reviews on our Part D ratings site – MedicareDrugPlans.com – are written by frustrated and angry American seniors who have discovered they will be paying much more money for prescription drugs in 2016. I, happily, concede that there are millions of satisfied seniors who are going about their year with good Part D coverage. For instance, so far my mom is happy (but I helped her pick her plan). Let’s face it: millions of others are not happy and they are rightfully venting. Let us know about your experiences with Medicare Part D this year, by rating and reviewing your plans. Note: We want to hear good reviews (we know some of you are happy with your plans) to help people find the best plans!
For an overview of the venting, check out the reviews below.
Plan: Cigna-HealthSpring Rx Secure – California
Review: This plan was $39 in 2015…increased to $77…I received no notification of the increase, and did not realize it had changed until I received my Jan credit card statement by then it was too late to make a change….I would absolutely not choose this company in the future. Major rip off for senior citizens!
Multiple Medicare Part D Mayhem
Plan: Humana Walmart Rx Plan – South Carolina
Review: Explanations of coverage terrible. They challenged our first two prescriptions although we had been taking them already. Looks like they almost automatically reject prescriptions and force you to get exceptions — wear you down. So far it’s everything bad you’ve heard about insurance companies. And the Wal-Mart guy (pharmacist)? I asked one question: ‘Which of these are tier one and two”. His ‘helpful” response. “I haven’t the faintest idea”
Drug Cost Smack
Plan: Blue MedicareRx Value Plus
Review: i enrolled and used plan for 4 months and then they bumped the cost of an in-office infusion therapy from $40 dollars per treatment, (every 8 weeks), to $862!!!!!!! No notification. Dropped them like a rock and off to MEDEX with separate plan for prescriptions.
Tagged with: Blue MedicareRx Value Plus, Cigna-HealthSpring Rx Secure, Humana Walmart Rx Plan, Medicare Part D, medicaredrugplans.com
Unfortunately, public scrutiny about high drug prices doesn’t usually lead to legislative fixes, such as passing legislation that would allow Medicare to negotiate drug prices with the pharmaceutical industry and expand the practice of safe personal drug importation so more consumers access lower prices from foreign pharmacies. On the other hand, a New York Times article – “Even Talking About Reducing Drug Prices Can Reduce Drug Prices” – suggests, well, that “talking about” drug prices can reduce them, because pharma executives get scared that if they don’t moderate drug prices, more permanent and progressive fixes will finally happen.
Tagged with: Bernie Sanders, Big Pharma, Drug Prices, Hilary Clinton, House Committee on Government and Oversight, Marco Rubio, Martin Shkreli, Medicare Improvement and Modernization Act of 2003, Medicare Part D, New York Times